Tom ShepherdCEO at Captor TherapeuticsSpeaker
Profile
Chief Executive Officer (President of the Management Board) at Captor Therapeutics S.A., a Polish Biopharmaceutical company listed on the Warsaw stock exchange focused on the discovery, development and commercialisation of innovative drugs in the rapidly growing field of targeted protein degradation. Tom has over thirty years’ experience of leadership positions in pharma and biotechnology companies in the UK, USA, France, Switzerland, Australia and Poland, securing 13 major license agreements, 6 private / VC investor rounds and 3 IPOs. Awarded a PhD in biochemistry from Strathclyde University, Glasgow, and the CEP diploma from the London Business School.
Agenda Sessions
Designing tomorrow’s biotech: The interdependent ecosystem of therapeutic areas, research collaborators, and innovative funding models
, 11:30View Session